Why the study?
Does intravenous propafenone improve the success rate of cardioversion in patients with atrial fibrillation refractory to standard external direct current cardioversion?
Does intravenous propafenone improve the success rate of cardioversion in patients with atrial fibrillation refractory to standard external direct current cardioversion?
Intravenous propafenone safely facilitates successful electrical cardioversion in patients with atrial fibrillation that is initially refractory to standard direct current cardioversion.
May facilitate cardioversion in refractory AF; case report leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Choi et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: